Argatroban Injection Recalled For Particle Contamination

The Medicines Company’s supplier, Eagle Pharmaceuticals Inc., has issued a voluntary nationwide recall of all four (4) lots of Argatroban Injection, 50 mg per 50 mL (“Argatroban”) from the market due to a potential for visible particulates, according to a safety alert issued from the U.S. Food & Drug Administration, dated March 23, 2012.

Argatroban works by blocking the natural substance thrombin, which is used by the body to form blood clots or can cause an opened blood vessel in the heart to close back up, said MedicineNet.

Eagle Pharmaceuticals Inc. is conducting this voluntary recall as a precautionary measure with the knowledge of the FDA.  This voluntary recall is being conducted nationwide at the wholesaler, pharmacy and distributor levels.

During an investigation, a visible particulate was discovered in a stability sample in one of the distributed lots. Upon re-inspection, a small number of visible particulates were discovered in several vials.

The risk of using an injectable product with particulates includes embolization/infarction to organs and potential organ complications.

The Medicines Company has not received any reports of adverse events related to this issue.

Eagle Pharmaceuticals Inc. has directed The Medicines Company to arrange for the return of the following lots from all services and facilities:

Lot V10189; expiration date January 2013

Lot V10191; expiration date January 2013

Lot V10194; expiration date January 2013

Lot V10223; expiration date February 2013

The Medicines Company can be reached, toll-free, at 1.888.977.6326 or by email at [email protected]

Any adverse events that may be related to the use of this product should be reported to The Medicines Company or to FDA’s MedWatch Program, either online, by regular mail, or by fax. FDA’s MedWatch Program.



, , ,

No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Medical Mattresses Pose Risk Of Infection And Contamination

The FDA warns that medical mattresses may not be as clean as once perceived. Routine checks on mattresses are advised as any rips, tears, or excessive wear alter the efficacy. The medical mattresses as well as the covers have an expected life depending on the manufacturer, which should not go unnoticed.

On Third Of Children Medications Are Only Tested On Adults Leading To Improper Use

One third of children medications are not tested on children, but rather adults. Thus, these drugs are approved for adult use. Companies base the dosages off the adult studies, increasing the risk for improper use.

Epilepsy Drug During Pregnancy Linked To Autism

Expectant mothers who take the popular anti-epileptic drug valproate during pregnancy should be aware that there is an increased risk for their child developing autism compared with children of women who did not take the epilepsy drug, according to a recently published Danish study. Valproate is a drug used for the treatment of epilepsy and other [...]

Cough Syrup Responsible For Over 36 Deaths

Pakistani authorities are investigating allegations that cough syrup has killed at least three dozen people, a government official has announced, making this the second time in recent months that medicine is suspected of causing multiple deaths. The deaths from the cough syrup occurred in the eastern city of Gujranwala and nearby villages, said local official [...]

Merck Settles Vioxx Class-Action Lawsuit

In almost a decade old battle, Merck & Co. Inc. has agreed to settle a class action lawsuit filed on behalf of Missouri consumers over its prescription pain reliever Vioxx in a deal that could cost the drugmaker up to $220 million, lawyers for the consumers said. According to CNBC, the agreement announced on November [...]

Latest Medical Device Injury News

Metal-on-Metal Hip Implants Cause Soft Tissue Damage Says FDA

Hip joint deterioration can lead to pain, stiffness or difficulty walking. When these symptoms do not respond to conservative treatment, such as physical therapy, patients may be advised to undergo total hip replacement or hip resurfacing. As part of this treatment, they may receive a “metal-on-metal” hip implant in which the “ball and socket” of [...]

Ethicon Recalls Surgical Stapler

The FDA has announced a voluntary global recall of more than 157,000 Ethicon surgical staplers, due to problems with incomplete firing strokes that may cause faulty staple formation, potentially resulting in painful and severe internal complications for the patient. An Ethicon surgical stapler recall was first announced in August, after reports surfaced where surgeons experienced [...]

Another Device Maker Investigated By DOJ

Earlier this month, cardiovascular device maker Abiomed announced that the US Attorney’s Office was investigating the company’s marketing and labeling of the Impella 2.5 circulatory support device. According to Forbes, the announcement confirmed rumors that had been circulating for at least two weeks, though in the press release the company said it had just been [...]

A Medical Device Horror Story

CNNMoney describes the chilling details of the bone cement horror stories surrounding the medical device company Synthes. In 2009 the U.S. attorney in Philadelphia accused the medical device manufacturer of running illegal clinical trials — essentially, experimenting on humans. Between 2002 and 2004, Synthes tested a product called Norian XR, a cement that has a [...]

Non-FDA Approved Stryker Surgical Device Recall And Alert

Stryker Neptune Waste Management System is the subject of a recent FDA recall and safety alert.  The non-FDA approved device can cause bleeding as well as soft tissue, muscle and vital organ damage. The Stryker Neptune Waste Management System is used during surgical procedures to collect fluid waste from the patient. The Neptune 2 Ultra [...]